Leigh Syndrome in Childhood: Neurologic Progression and Functional Outcome
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Few studies have analyzed the clinical course and functional outcome in Leigh syndrome (LS). The aim of this study was to determine the clinical, radiological, biochemical, and genetic features of patients with LS, and identify prognostic indicators of the disease progression and neurological outcome. Methods Thirty-nine patients who had been diagnosed with LS at the Seoul National University Children’s Hospital were included. Their medical records, neuroimaging findings, and histological/biochemical findings of skeletal muscle specimens were reviewed. Targeted sequencing of mitochondrial DNA was performed based on mitochondrial respiratory chain (MRC) enzyme defects. Results Isolated complex I deficiency was the most frequently observed MRC defect (in 42% of 38 investigated patients). Mitochondrial DNA mutations were identified in 11 patients, of which 81.8% were MT-ND genes. The clinical outcome varied widely, from independent daily activity to severe disability. Poor functional outcomes and neurological deterioration were significantly associated with early onset (before an age of 1 year) and the presence of other lesions additional to basal ganglia involvement in the initial neuroimaging. Conclusions The neurological severity and outcome of LS may vary widely and be better than those predicted based on previous studies. We suggest that age at onset and initial neuroimaging findings are prognostic indicators in LS
Abstract
Background and Purpose Few studies have analyzed the clinical course and functional outcome in Leigh syndrome (LS). The aim of this study was to determine the clinical, radiological, biochemical, and genetic features of patients with LS, and identify prognostic indicators of the disease progression and neurological outcome. Methods Thirty-nine patients who had been diagnosed with LS at the Seoul National University Children’s Hospital were included. Their medical records, neuroimaging findings, and histological/biochemical findings of skeletal muscle specimens were reviewed. Targeted sequencing of mitochondrial DNA was performed based on mitochondrial respiratory chain (MRC) enzyme defects. Results Isolated complex I deficiency was the most frequently observed MRC defect (in 42% of 38 investigated patients). Mitochondrial DNA mutations were identified in 11 patients, of which 81.8% were MT-ND genes. The clinical outcome varied widely, from independent daily activity to severe disability. Poor functional outcomes and neurological deterioration were significantly associated with early onset (before an age of 1 year) and the presence of other lesions additional to basal ganglia involvement in the initial neuroimaging. Conclusions The neurological severity and outcome of LS may vary widely and be better than those predicted based on previous studies. We suggest that age at onset and initial neuroimaging findings are prognostic indicators in LS
참고문헌 (19)
- Finsterer J, "Leigh and Leigh-like syndrome in children and adults", Pediatr Neurol, 39, pp.223~235 (2008)
- Baertling F, "A guide to diagnosis and treatment of Leigh syndrome", J Neurol Neurosurg Psychiatry, 85, pp.257~265 (2014)
- Leigh D, "Subacute necrotizing encephalomyelopathy in an infant", J Neurol Neurosurg Psychiatry, 14, pp.216~221 (1951)
- Mak SC, "Mitochondrial DNA 8993 T > C mutation presenting as juvenile Leigh syndrome with respiratory failure", J Child Neurol, 13, pp.349~351 (1998)
- Sobreira C, "Leigh-like syndrome with the T8993G mutation in the mitochondrial ATPase 6 gene: long-term follow-up discloses a slowly progressive course", J Neurol Sci, 278, pp.132~134 (2009)
- Jin T, "Clinical, pathological, and neuroimaging analyses of two cases of Leigh syndrome in a Chinese family", J Child Neurol, 29, pp.NP143~NP148 (2014)
- Sofou K, "A multicenter study on Leigh syndrome: disease course and predictors of survival", Orphanet J Rare Dis, 9, pp.52~ (2014)
- Debray FG, "Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases", Pediatrics, 119, pp.722~733 (2007)
- DiMauro S, "Cytochrome c oxidase deficiency in Leigh syndrome", Ann Neurol, 22, pp.498~506 (1987)
- Ingman M, "mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences", Nucleic Acids Res, 34(Database issue), pp.D749~D751 (2006)
- Lee HF, "Leigh syndrome: clinical and neuroimaging follow-up", Pediatr Neurol, 40, pp.88~93 (2009)
- Yang YL, "Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome", Chin Med J (Engl), 119, pp.373~377 (2006)
- Wang Z, "Phenotypic patterns of MELAS", LS overlap syndrome associated with m.13513G>A mutation, and neuropathological findings in one autopsy case, 2010, pp.30, 606~614
- Leng Y, "The mitochondrial DNA 10197 G > A mutation causes MELAS", Leigh overlap syndrome presenting with acute auditory agnosia, 2015, pp.26, 208~212
- Koenig MK, "Presentation and diagnosis of mitochondrial disorders in children", Pediatr Neurol, 38, pp.305~313 (2008)
- Ma YY, "Genetic and biochemical findings in Chinese children with Leigh syndrome", J Clin Neurosci, 20, pp.1591~1594 (2013)
- Chae JH, "Biochemical and genetic analysis of Leigh syndrome patients in Korea", Brain Dev, 30, pp.387~390 (2008)
- Ma YY, "A study of 133Chinese children with mitochondrial respiratory chain complex I deficiency", Clin Genet, 87, pp.179~184 (2015)
- Naess K, "MtDNA mutations are a common cause of severe disease phenotypes in children with Leigh syndrome", Biochim Biophys Acta, 1787, pp.484~490 (2009)